Cordatus Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Sell |
16,500
-7
| -0% | -$1.3K | 0.75% | 35 |
|
|
2025
Q1 | $3.46M | Buy |
16,507
+527
| +3% | +$110K | 0.95% | 28 |
|
|
2024
Q4 | $2.84M | Buy |
15,980
+642
| +4% | +$114K | 0.75% | 41 |
|
|
2024
Q3 | $3.03M | Buy |
15,338
+146
| +1% | +$28.8K | 1.09% | 25 |
|
|
2024
Q2 | $2.61M | Buy |
15,192
+2,100
| +16% | +$360K | 0.98% | 28 |
|
|
2024
Q1 | $2.38M | Buy |
13,092
+70
| +0.5% | +$12.7K | 1.73% | 18 |
|
|
2023
Q4 | $2.02M | Sell |
13,022
-1,626
| -11% | -$252K | 1.67% | 18 |
|
|
2023
Q3 | $2.18M | Sell |
14,648
-153
| -1% | -$22.8K | 1.99% | 16 |
|
|
2023
Q2 | $1.99M | Buy |
14,801
+12,938
| +694% | +$1.74M | 0.75% | 45 |
|
|
2023
Q1 | $297K | Hold |
1,863
| – | – | 0.38% | 52 |
|
|
2022
Q4 | $301K | Buy |
+1,863
| New | +$301K | 0.44% | 48 |
|